https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Patients with chronic kidney disease, dialysis patients and kidney-transplant patients are at high risk of developing severe coronavirus disease-19 (COVID-19). Data regarding the immunogenicity of anti-Severe Acute Respiratory Syndrome coronavirus-2 messenger RNA (anti-SARS-CoV-2 mRNA) vaccines in dialysis patients were published recently. We assessed the immunogenicity of anti-SARS-CoV-2 mRNA vaccine in dialysis patients. One hundred-nine patients on hemodialysis (n = 85) or peritoneal dialysis (n = 24) have received two i
Like
Comment
Share
